Washington, DC Bids > Bid Detail

Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)

Agency: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Level of Government: Federal
Category:
  • A - Research and development
Opps ID: NBD00159551337348595
Posted Date: Aug 23, 2023
Due Date:
Solicitation No: 75A50123C00040
Source: https://sam.gov/opp/279eeec947...
Follow
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Active
Contract Opportunity
Notice ID
75A50123C00040
Related Notice
BARDABAA
Contract Line Item Number
75A50123C00040
Department/Ind. Agency
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier
OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office
ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Award Details
  • Contract Award Date: Aug 22, 2023
  • Contract Award Number: 75A50123C00040
  • Task/Delivery Order Number:
  • Contractor Awarded Unique Entity ID:
  • Contractor Awarded Name: amgen
  • Contractor Awarded Address: Thousand Oaks , CA USA
  • Base and All Options Value (Total Contract Value): $7,290,923.50
General Information
  • Contract Opportunity Type: Award Notice (Original)
  • All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA
  • Original Published Date: Aug 23, 2023 01:27 pm EDT
  • Inactive Policy: 15 days after contract award date
  • Original Inactive Date: Sep 06, 2023
  • Initiative:
    • None
Classification
  • Original Set Aside:
  • Product Service Code: AN13 - Health R&D Services; Health care services; Experimental Development
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    Washington , DC 20515
    USA
Description

Develop a Kit for the administration of Nplate® (Romiplostim) for treatment of Hematopoietic Syndrome Acute Radiation Syndrome (HS-ARS). Kit development will lead to an FDA approved combination product (Nplate® medicine + medical devices for injection). The co-packaged combination product (e.g., Nplate drug and the Kit will be stockpiled separately) will enable commercial use of the Nplate® drug in the U.S. and stockpiling of the Kit and Nplate® by BARDA.


Attachments/Links
Contact Information
Contracting Office Address
  • 200 Independence Avenue, SW
  • Washington , DC 20201
  • USA
Primary Point of Contact
Secondary Point of Contact


History

TRY FOR FREE

Not a USAOPPS Member Yet?

Get unlimited access to thousands of active local, state and federal government bids and awards in All 50 States.

Start Free Trial Today >